Cancer AI Startup Triomics raises $22M amid growing oncology workloads
Triomics has secured $22 million in Series B funding to expand its oncology AI platform used by cancer centers. The investment comes as global cancer cases continue to rise, increasing demand for tools that help healthcare providers manage patient records, clinical trials, and reporting requirements.